Pacira | PCRX - 销售毛利

股票价格

25.14

每天变化

-0.27 -1.06%

每月一次

8.04%

每年

-6.54%

Q2 预测

23.99

金融业

USD

USD 1.26B

现金及等价物

USD 158.55M

USD 54.62M

USD 547.97M

USD 120.59M

USD 372.19M

USD 3.19M

USD 38.71M

790

EPS每股收益

USD 0.06

股本和储备

USD 693.11M

USD 142.25M

债务利息支出

USD 3.89M

USD 8.53M

USD 372.19M

USD 1.18B

USD 1.64M

USD 193.68M

USD 3.19M

普通股股本

USD 41.12M

52.68

USD 9.52M

USD 196.87M

销售和管理费用

USD 91.87M

USD 152.86M

贸易债权人

USD 15.15M

应收帐款人

USD 124.07M

	销售毛利	更改		日
Assertio Holdings	USD 22.24M		970K	2024-06
Astellas Pharma	JPY 444.26B		12.55B	2026-03
Bristol-Myers Squibb	USD 8.79B		110M	2025-09
Cara Therapeutics	USD 2.57M		1.11M	2025-03
Coherus Biosciences	USD 8.7M		853K	2025-12
Heron Therapeutics	USD 29.47M		3.17M	2025-12
Ironwood Pharmaceuticals	USD 85.24M		44.1M	2025-06
J&J	USD 17.24B		642M	2026-03
Ligand Pharmaceuticals	USD 155.28M		82.42M	2025-09
Nektar Therapeutics	USD 21.81M		8.06M	2025-12
Novo Nordisk	DKK 64.01B		1.19B	2025-06
Omeros	USD -33.16M		18.52M	2024-06
Pacira	USD 142.25M		11.34M	2025-12
Perrigo	USD 362.2M		14.9M	2025-12
Pfizer	USD 3.54B		7.61B	2025-09
Supernus Pharmaceuticals	USD 164.04M		15.23M	2025-12
Teva Pharmaceutical Industries	USD 2.11B		547M	2026-03
Xeris Pharmaceuticals	USD 72.15M		8.77M	2025-12
Xoma	992K		846K	2024-06
Zoetis	USD 1.64B		73M	2025-12